Indication
Bladder cancer
1 clinical trial
1 product
Product
NanoDoceClinical trial
Phase 1/2 Trial Evaluating the Safety and Tolerability of NanoDoce® Injection and Intravesical Instillation in Subjects With Urothelial CarcinomaStatus: Completed, Estimated PCD: 2021-11-02